Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC - Drug Trials For Money - Paid Clinical Trials

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
Conditions:   Metastatic Prostate Cancer;   Prostate Adenocarcinoma
Interventions:   Drug: Cabozantinib;   Drug: Atezolizumab;   Drug: Abiraterone Acetate;   Drug: Enzalutamide;   Drug: Prednisone
Sponsors:   Exelixis;   Roche-Genentech;   Takeda
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 2, 2020 / by / in
Comments